Antibody-Drug Conjugates Market Major Players with Report Data 2028

Comments · 125 Views

Market Size – USD 3.18 Billion in 2020, Market Growth – at a CAGR of 25.8%, Market Trends – Increasing prevalence of cancer globally

 

 

The latest research report serves as a perfect example of the precise analysis of the global Antibody-Drug Conjugates (ADCs) market. It includes the ToC, list of tables and figures, research methodology, geographic segmentation, competitive landscape, future developments, and technological innovation. Moreover, the report offers the latest coverage of the massive impact of the COVID-19 pandemic on the worldwide Antibody-Drug Conjugates Market industry. The globally-disrupting incidence has impacted nearly every aspect of this business domain. However, the latest study expounds on the present market scenario and forecasts the pandemic’s aftermath, with respect to this industry

 

The global Antibody-Drug Conjugates (ADCs) market size is expected to reach USD 20.01 Billion at a steady revenue CAGR of 25.8% in 2028, according to latest analysis by Emergen Research. Increasing prevalence of cancer along with growing geriatric population is driving antibody-drug conjugates market revenue growth. Antibody drug conjugates are used to treat cancer and are safer than other types of cancer therapies.Antibody-drug conjugates are highly targeted therapies that use biopharmaceutical drugs comprising monoclonal antibodies to target tumor cell specific antigens and extremely potent anti-cancer drugs linked through chemical linker. ADCs are considered a powerful and highly effective class of therapeutic agents used in oncology and hematology. ADC technology is also used outside of cancer-related indications.

 

To get access to the complete report @ https://www.emergenresearch.com/industry-report/antibody-drug-conjugates-market

 

Covid 19 impact analysis:

 

The report contains updated information about the ongoing COVID-19 pandemic and acts as an accurate analysis of the COVID-19 impact on the Antibody-Drug Conjugates Market . The report draws attention to the COVID-19 impact on the market and its crucial segments. As per the report, the current pandemic is one of the major contributing elements for the potential decline of the market in the coming years. The business sector has been drastically affected by the pandemic, which has adversely altered the market dynamics and demand trends. Financial difficulties brought by the pandemic have delayed the progress rate of various businesses and disrupted the global supply chains. The report further provides a future impact assessment of the Antibody-Drug Conjugates Market concerning COVID-19.

Key players in the market include Oxford BioTherapeutics, Bayer AG, Immunomedics Inc., Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Pfizer Inc., ImmunoGen Inc., AbbVie Inc., Sanofi S.A., and Takeda Pharmaceutical Company Limited.

 Global Antibody-Drug Conjugates Market Geographical Landscape - Synopsis:

  • The report closely studies the growth trajectory of the global Antibody-Drug Conjugates Market . It brings to light the global dominance of the leading regional segments, including North America, Asia Pacific, Europe, Latin America, and the Middle East Africa.
  • The study elaborates on the crucial information pertaining to the regional market share. It simultaneously focuses on the significant details about the growth patterns of each regional market.
  • Moreover, the report encases an exhaustive geographical study of the market, emphasizing the business growth prospects and market barriers for each of the key market regions.

Emergen Research has segmented the global Antibody-Drug Conjugates market on the basis of technology, application, end-use, and region:

Technology Outlook (Revenue, USD Billion; 2018–2028)

  • Cleavable Linker
  • Non-Cleavable Linker

Application Outlook (Revenue, USD Billion; 2018–2028)

  • Blood Cancer
    1. Leukemia
    2. Lymphoma
  • Brain Tumor
  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Others

End-use Outlook (Revenue, USD Billion; 2018–2028)

  • Hospitals
  • Research Institute
  • Clinics

 Report Highlights:

 

  • The report conducts a comparative assessment of the leading market players participating in the global Antibody-Drug Conjugates Market .
  • The report marks the notable developments that have recently taken place in the Antibody-Drug Conjugates Market tindustry
  • It details on the strategic initiatives undertaken by the market competitors for business expansion.
  • It closely examines the micro- and macro-economic growth indicators, as well as the essential elements of the Antibody-Drug Conjugates Market value chain.
  • The repot further jots down the major growth prospects for the emerging market players in the leading regions of the market.

 

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Find similar reports @

Oncology Informatics Market @ https://www.emergenresearch.com/industry-report/oncology-informatics-market

Interventional Oncology Devices Market @ https://www.emergenresearch.com/industry-report/interventional-oncology-devices-market

eHealth Market @ https://www.emergenresearch.com/industry-report/ehealth-market

Medical Wearable Market @ https://www.emergenresearch.com/industry-report/medical-wearable-market

Healthcare Supply Chain Management Market @ https://www.emergenresearch.com/industry-report/healthcare-supply-chain-management-market

Laboratory Informatics @ https://www.emergenresearch.com/industry-report/laboratory-informatics-market

Ozone Generator @ https://www.emergenresearch.com/industry-report/ozone-generator-market

Patient Registry Software @ https://www.emergenresearch.com/industry-report/patient-registry-software-market

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

 

 

Comments